Voya Financial delivered a solid second quarter in a diversified, capital-light framework. Adjusted operating earnings per share (EPS) were $2.18 in Q2 2024, modestly below the prior-year level of $2.21, driven by higher Health loss ratios which management expects to be addressed with pricing actions into 2025. GAAP net income rose to $201 million from $154 million a year earlier, aided by more favorable investment gains and lower acquisition costs. The company reaffirmed its full-year target of $8.25 to $8.45 in adjusted operating EPS for 2024 and highlighted robust excess capital generation (~$200 million in the quarter) and capacity to return over $800 million to shareholders in 2024 through buybacks and dividends, including a dividend increase of $0.05. In Wealth, net flows are expected to be positive in the second half as known sales rose 30% year-over-year, with Full Service and recordkeeping activity supported by mid-market growth and government channels. Investment Management (IM) posted $4.8 billion of net inflows in Q2 and remains on track for about 2% organic growth for 2024, aided by a broad mix of institutional fixed income, retail, and private/alternative strategies, plus a plan to launch three new funds in H2 2024. A key strategic complexity remains in Health Stop Loss, where aggregate loss ratios in Q2 were 72.9% (vs. a target of 69–72%), with management signaling a path back to 77–80% in 2025 through rate actions and underwriting discipline. Management emphasized ongoing strategic execution, disciplined spend, and capital management, including refinancing $400 million of debt due in 1H 2025 and continued pursuit of excess capital above 90% of earnings. The call also highlighted the Benefitfocus platform as a meaningful driver of HSA sales and participant engagement, and the transition of remaining Venerable-run assets over the next 12–18 months. Overall, the company maintains a constructive outlook supported by diversified revenue streams, ongoing product and distribution enhancements, and a clear plan to restore Health loss ratios while continuing to grow cash flow and capital deployment discipline.